Samson Yun‐Sang Chan

Chinese University of Hong Kong

Papers

1

Total Citations

4

H-Index

1

About

Samson Yun‑Sang Chan is a urologic surgeon and clinical researcher whose work centers on improving surgical outcomes in prostate cancer care, particularly through the prevention of postoperative complications. His key research areas include robotic-assisted radical prostatectomy, pelvic lymph node dissection, and the management of lymphatic leaks. Chan’s major contribution is the first randomized controlled trial evaluating Hemopatch—a novel hemostatic patch—to prevent lymphatic leakage after robotic prostatectomy and bilateral pelvic lymph node dissection. This prospective, single‑center, phase III study, published in 2022, provides early evidence for a simple, intraoperative intervention that could reduce morbidity and hospital stay. Although the trial has garnered 4 citations to date, its clinical relevance is growing as surgeons seek effective strategies to manage lymphatic complications. Chan’s work exemplifies the translation of surgical innovation into evidence‑based practice, and his ongoing research continues to refine perioperative care in urologic oncology. For students and researchers, his study highlights the importance of rigorous trial design in evaluating emerging technologies.

Research Focus

Key Achievements

1
H-Index
1
Papers
4
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
Hemopatch to Prevent Lymphatic Leak after Robotic Prostatectomy and Pelvic Lymph Node Dissection: A Randomized Controlled Trial
4 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Chinese University of Hong Kong

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago